Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study

Morten Blinkenberg, Henrik K Mathiesen, Thomas Tscherning, Agnete Jønsson, Claus Svarer, Søren Holm, Finn Sellebjerg, Olaf B Paulson, Lars G. Hanson, Per S Sorensen

Research output: Contribution to journalJournal articlepeer-review

Abstract

OBJECTIVES: Positron emission tomography (PET) studies have shown that cortical cerebral metabolic rate of glucose (CMRglc) is reduced in multiple sclerosis (MS). Quantitative magnetic resonance spectroscopy (MRS) measures of N-acetyl-aspartate (NAA) normalized to creatine (NAA/Cr) assess neuronal deterioration, and several studies have shown reductions in MS. Furthermore, both PET and MRS reductions correlate with cognitive dysfunction in MS. Our aim was to determine if changes in cortical CMRglc in early MS correlate with NAA/Cr measurements of neuronal deterioration, as well as cognitive dysfunction and neurological disability. METHODS: We studied 20 recently diagnosed, clinically definite, relapsing-remitting MS patients. Global and cortical CMRglc was estimated using PET with 18-F-deoxyglucose and NAA/Cr ratio was measured using multislice echo-planar spectroscopic imaging. All subjects were neuro-psychologically tested and a cognitive dysfunction factor (CDF) was calculated. RESULTS: Cortical CMRglc correlated with cortical NAA/Cr (r = 0·45; P
Original languageEnglish
JournalNeurological Research
Volume34
Issue number1
Pages (from-to)52-58
ISSN0161-6412
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study'. Together they form a unique fingerprint.

Cite this